Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $35 Call had some of the highest implied volatility...
On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.32%. Stocks rallied on...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. Stocks are climbing today, supported...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.74%. Stocks today are trading moderately...
Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year over year. However, the bottom line missed the Zacks Consensus Estimate by 0.9%.The...
/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Hologic is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.
/CNW/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However, this...
/Hologic%2C%20Inc_%20logo%20outside%20building%20by-%20Tada%20Images%20via%20Shutterstock.jpg)
Hologic has recently outperformed in the Nasdaq, and Wall Street analysts are moderately bullish about the stock’s prospects.